Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ICAM-1 orchestrates radiotherapy abscopal effect

April 23, 2021

Tolremo Therapeutics describes new DYRK1B inhibitors

April 23, 2021

Shanghai Litedd identifies new ROR-gammaT agonists

April 23, 2021

Chinese investigators disclose HGFR and/or SRC and/or CSF1R inhibitors

April 23, 2021

Monopteros initiates phase I/Ib study of MPT-0118 in solid tumors

April 23, 2021

First patient dosed in investigator-initiated study of rigosertib in RDEB-associated SCC

April 23, 2021

Studies reveal activity, mechanism of TAM kinase inhibitor PF-5807

April 23, 2021

Boragen identifies new JAK inhibitors

April 22, 2021

Nirogyone Therapeutics discloses MCT inhibitors

April 22, 2021

Dosing starts in phase I study of AL-102 in combination with WVT-078 in patients with MM

April 22, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...